PATH
Menu

Filter browse results

Total results with these characteristics: 190

Subject: Health technologies > Vaccine delivery
Publication date: All

Page 7 of 10
Assessment of the Vaccine Supply Chain for Fee-Based Immunization in Hanoi Capital and Ho Chi Minh City

The objective of this project Optimize assessment was to understand the structure, scope, and quality of the vaccine supply chain for fee-based immunization services and to provide recommendations for strengthening management and monitoring the quality of the vaccine supply chain for fee-based immunization.

Publication date: April 2011

Region: Asia

Exploring the Role of the US Government in a Future Advance Market Commitment: Recommendations for Policymakers

This fact sheet from the Global Health Technologies Coalition provides specific recommendations to US policymakers about the role and engagement of the US government in a future advance market commitment.

Publication date: March 2011

Region: North America and Europe

The Transformative Power of Global Health Research: Leadership in Innovation Saves Lives and Provides Economic Benefits to the US

This fact sheet from the Global Health Technologies Coalition examines how US leadership in global health research helps to saves lives worldwide and provides domestic economic benefits.

Publication date: March 2011

Region: North America and Europe

Vaccine Vial Monitors: FAQs

Vaccine vial monitors (VVMs) are small stickers that adhere to vaccine vials and change color as the vaccine is exposed to heat, letting health workers know whether the vaccine can be safely used for immunization. This fact sheet answers the most frequently asked questions regarding VVMs.

Publication date: January 2011

Region: Global

Evaluating HPV Vaccine Delivery Strategies in Vietnam

This report is a synthesis of the project Evaluating HPV Vaccine Delivery Strategies in Vietnam, which aimed to identify appropriate strategies for human papillomavirus (HPV) vaccine delivery in different geographic and socioeconomic conditions. The report summarizes results of both the implementation and research aspects of the project. The document is available as one large file or as four smaller files for easier downloading.

Publication date: December 2010

Region: Asia

Collaborating With Countries to Improve Supply Chains

Project Optimize—a collaboration between the World Health Organization and PATH—aims to employ technological and scientific advances in the immunization field. This document describes efforts to define ideal specifications for health products and create a flexible and robust vaccine supply chain that can handle an increasingly large and costly portfolio of vaccines.

Publication date: November 2010

Region: Global

An Integrated Approach to Health Information Systems in Guatemala

This project Optimize document describes an effort by the World Health Organization, PATH, the Pan American Health Organization, and the Guatemala Ministry of Public Health and Social Services to address challenges related to vaccine introduction. The goal is to develop an information system that will enable the digital recording and transmission of immunization data.

Publication date: November 2010

Region: Global

A Review of the United States Centers for Disease Control and Prevention Vaccine Management Business Improvement Project

In this document, project Optimize reviews the US Centers for Disease Control and Prevention’s (CDC’s) Vaccine Management Business Improvement Project, which represents an end-to-end reengineering of the US public-sector vaccine supply chain—from vaccine budgeting through storage and distribution. The CDC’s overarching goal was to ensure that vaccine was flowing to the right places at the right time.

Author: Wasserman N

Publication date: November 2010

Region: Global

Incentives and Innovative Financing for Global Health Product Development

This fact sheet from the Global Health Technologies Coalition explores different incentives and innovative financing mechanisms and their role in global health product development.

Publication date: October 2010

Region: North America and Europe

Incremental Costs of Introducing Jet Injection Technology for Delivery of Routine Childhood Vaccinations: Comparative Analysis From Brazil, India, and South Africa

Disposable-syringe jet injectors have the potential to deliver vaccines safely and affordably. However, there are complex cost considerations that must be taken into account with any new technology. This article, published in Vaccine, estimates the incremental costs of transitioning from needles and syringes to delivering childhood vaccines with disposable-syringe jet injectors in Brazil, India, and South Africa.

Author: Griffiths UK, Santos AC, Nundy N, Jacoby E, Matthias D

Publication date: October 2010

Region: Global

PATH Today (Fall 2010)

This issue of PATH Today highlights new, innovative technologies coming from the lab and shop at PATH, a spotlight on the December launch of the meningitis vaccine in Western Africa, and a tuberculosis project in Tanzania. Also noted is the 1+1 Challenge, expanding PATH’s presence with new country offices in Africa, and the announcement of a new leader for PATH's India country program.

Publication date: October 2010

Region: Global

Part of series: PATH Today

Monitoring Ambient and Cold Chain Temperatures During Delivery of Human Papillomavirus Vaccine in Vietnam and Uganda: Summary Report

As part of project Optimize, a five-year human papillomavirus (HPV) vaccine demonstration project is under way in Vietnam, Uganda, India, and Peru to generate evidence for government decision-making about successful vaccine delivery strategies to provide HPV vaccine to young adolescent girls. HPV vaccine is a strong candidate for storage and transport in a controlled temperature chain at temperatures higher than the standard 2° to 8°C cold chain storage.

Publication date: September 2010

Region: Global

Vaccine Technologies at PATH

PATH and our partners have been advancing innovative vaccine technologies for more than 30 years. This report outlines our approach and capabilities. It also describes a number of individual vaccine technologies at various stages of development and market introduction to put this work in context. 

Publication date: September 2010

Region: Global

Breakeven Analysis for Various Human Papillomavirus Vaccine Presentations in Vietnam and Uganda

The study highlighted in this project Optimize report uses a breakeven cost analysis to compare potential prices, wastage rates, and cold chain requirements for various human papillomavirus (HPV) vaccine presentations.

Publication date: August 2010

Region: Global

Vaccine Vial Monitor (VVM) Availability and Use in the African, Eastern Mediterranean, Southeast Asian, and Western Pacific Regions

Commissioned by project Optimize, a collaboration of PATH and the World Health Organization, a study of vaccine vial monitor (VVM) availability and use in developing countries in four regions was undertaken. The study had three aspects: the total proportion of vaccines with VVMs in the regions with detailed information by country, in-depth information on policies and practices, and knowledge and attitudes in a selected sample of countries.

Author: Milstein J

Publication date: August 2010

Region: Global

Cold Chain Temperature Monitoring in Vietnam: Monitoring Ambient and Cold Chain Temperatures During Delivery of Human Papillomavirus Vaccine

Human papillomavirus (HPV) vaccine is intended to prevent cervical cancer. As part of project Optimize, a two-year HPV vaccine demonstration project is being conducted to demonstrate how existing delivery systems can be adapted to successfully provide HPV vaccine to young adolescent girls. HPV vaccine is a strong candidate for out-of-the-cold-chain use given its characteristics of high heat stability and freeze sensitivity.

Author: Robertson J, Vu H, Le N, et al.

Publication date: July 2010

Region: Global

Immunization Logistics and Supply Systems: From Vision to Action

In July 2010, project Optimize held workshops in Washington, DC, and Seattle, WA, to engage stakeholders from a wide variety of organizations. The workshops discussed developing-country immunization systems and sought participant perspectives on the desired future state of the systems. This document provides a summary of the workshops.

Publication date: July 2010

Region: Global

Temperature Recording System in National Vaccine Stores of Khartoum, Sudan, and Tehran, Iran

Both Iran and Sudan utilize an alarm-based temperature recording system to monitor the performance of their national immunization cold stores. To better the utility and application of such systems in other countries, this project Optimize report documents the benefits, challenges, and advantages of both Iran’s and Sudan’s systems.

Author: Haghgou, M

Publication date: May 2010

Region: Global

Improving the Affordability of Inactivated Poliovirus Vaccines (IPV) for Use in Low- and Middle-Income Countries: An Economic Analysis of Strategies to Reduce the Cost of Routine IPV Immunization

This report from the vaccine technologies team at PATH presents results from an economic model that calculates the costs involved in delivering IPV vaccine in Indian immunization clinics according to three strategies: (1) intradermal delivery of reduced volumes of vaccine per dose, (2) use of adjuvants to allow a reduced IPV antigen content per dose, and (3) reduction of the number of doses per IPV immunization schedule. The strategies include delivery by standard technique and with alternative delivery devices.

Author: Hickling J, Jones R, Nundi N, Zehrung D

Publication date: April 2010

Region: Global

Monitoring Ambient Temperatures Experienced During Delivery of Human Papillomavirus Vaccine in Uganda

As part of project Optimize, a five-year human papillomavirus (HPV) vaccine demonstration project is under way in Uganda and three other countries to demonstrate how existing health systems can be adapted to successfully provide HPV vaccine to young adolescent girls. HPV vaccine is a strong candidate for storage and transport in a controlled temperature chain at temperatures higher than the standard 2º to 8ºC cold chain storage.

Author: Robertson J, Mugisha E, Kumakech E, LaMontagne D, Janmohamed A, Kristensen D, Seruyange R, Bamwine J, Ssekito G, Newland S

Publication date: April 2010

Region: Global

Page 7 of 10